BioAffinity Financial Statements From 2010 to 2026
BioAffinity Technologies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BioAffinity Technologies' valuation are provided below:bioAffinity Technologies does not presently have any fundamental signals for analysis.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Check BioAffinity Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAffinity Technologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . BioAffinity financial statements analysis is a perfect complement when working with BioAffinity Technologies Valuation or Volatility modules.
BioAffinity | Build AI portfolio with BioAffinity Stock |
bioAffinity Technologies Company Operating Margin Analysis
BioAffinity Technologies' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current BioAffinity Technologies Operating Margin | (1.59) % |
Most of BioAffinity Technologies' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, bioAffinity Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, bioAffinity Technologies has an Operating Margin of -1.5856%. This is 95.48% lower than that of the Biotechnology sector and 97.5% lower than that of the Health Care industry. The operating margin for all United States stocks is 71.22% lower than that of the firm.
bioAffinity Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioAffinity Technologies's current stock value. Our valuation model uses many indicators to compare BioAffinity Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioAffinity Technologies competition to find correlations between indicators driving BioAffinity Technologies's intrinsic value. More Info.bioAffinity Technologies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value BioAffinity Technologies by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Currently Active Assets on Macroaxis
When determining whether bioAffinity Technologies is a strong investment it is important to analyze BioAffinity Technologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BioAffinity Technologies' future performance. For an informed investment choice regarding BioAffinity Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAffinity Technologies. If investors know BioAffinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAffinity Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of bioAffinity Technologies is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies' value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAffinity Technologies' market value can be influenced by many factors that don't directly affect BioAffinity Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAffinity Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAffinity Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAffinity Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.